Home/Filings/4/A/0001601364-15-000002
4/A//SEC Filing

Versartis, Inc. 4/A

Accession 0001601364-15-000002

CIK 0001513818operating

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 5:31 PM ET

Size

9.4 KB

Accession

0001601364-15-000002

Insider Transaction Report

Form 4/AAmended
Period: 2015-01-22
Transactions
  • Purchase

    Common Stock

    2015-01-22$17.25/sh+55,000$948,7502,271,558 total(indirect: See FN)
Holdings
  • Option (Right to Buy)

    (indirect: See FN)
    Exercise: $21.00Exp: 2024-03-19Common Stock (35,000 underlying)
    35,000
Transactions
  • Purchase

    Common Stock

    2015-01-22$17.25/sh+55,000$948,7502,271,558 total(indirect: See FN)
Holdings
  • Option (Right to Buy)

    (indirect: See FN)
    Exercise: $21.00Exp: 2024-03-19Common Stock (35,000 underlying)
    35,000
Footnotes (3)
  • [F1]Securities are held by Advent Life Sciences LLP ("Advent") and Advent Life Sciences Fund I LP ("Advent Fund"). Advent is the general partner of Advent Fund. Advent disclaims beneficial ownership of the shares held by Advent Fund except to the extent of its indirect pecuniary interest therein. Shahzad Malik, an affiliate of the Reporting Persons, is a member of the Issuer's board of directors, and disclaims beneficial ownership of the shares held by Advent or the Advent Fund except to the extent of his indirect pecuniary interest therein.
  • [F2]One-fourth of the total number of shares subject to the option shall vest and become exercisable one year from 3/21/2014 (the "Vesting Commencement Date") and 1/36th of the remaining number of shares subject to the option shall vest and become exercisable on each monthly anniversary of the Vesting Commencement Date thereafter.
  • [F3]Securities are held by Shahzad Malik, an affiliate of the Reporting Persons. The Reporting Persons disclaim beneficial ownership of the securities held by Shahzad Malik.

Issuer

Versartis, Inc.

CIK 0001513818

Entity typeoperating
IncorporatedTX

Related Parties

1
  • filerCIK 0001513818

Filing Metadata

Form type
4/A
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 5:31 PM ET
Size
9.4 KB